Combined conjugated esterified estrogen plus methyltestosterone supplementation and risk of breast cancer in postmenopausal women.

Maturitas 2014 Sep 16;79(1):70-6. Epub 2014 Jun 16.

Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, United States.

Objectives: Testosterone supplementation is being prescribed increasingly to treat symptoms of hormone deficiency in pre- and postmenopausal women; however, studies of the association of testosterone therapy, alone or in combination with estrogen, with risk of breast cancer are limited. The current study assessed the association of combination conjugated esterified estrogen and methyltestosterone (CEE+MT) use and breast cancer risk in postmenopausal women in the Women's Health Initiative (WHI).

Study Design: At Year 3 of follow-up, women in the WHI observational study (N=71,964) provided information on CEE+MT use in the past two years, duration of use, and the brand name of the product. In addition, in each of years 4-8, women were asked whether they had used CEE+MT in the previous year. After 10 years of follow-up, 2832 incident breast cancer cases were identified. Cox proportional hazards models were used to estimate hazard ratios (HR) and 95% confidence intervals (95% CI) for the association of CEE+MT use (irrespective of use of other hormones) and of exclusive CEE+MT use in relation to breast cancer risk.

Results: Neither CEE+MT use nor exclusive use of CEE+MT was associated with risk: multivariable-adjusted HR 1.06, 95% CI 0.82-1.36 and HR 1.22, 95% CI 0.78-1.92, respectively. Among women with a natural menopause, the HR for exclusive use was 1.32 (95% CI 0.68-2.55). There was no indication of an association when repeated measures of CEE+MT use were included in a time-dependent covariates analysis.

Conclusion: The present study, the largest prospective study to date, did not show a significant association of CEE+MT supplementation and risk of breast cancer.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.maturitas.2014.06.006DOI Listing
September 2014
52 Reads

Publication Analysis

Top Keywords

breast cancer
24
postmenopausal women
12
risk breast
12
cee+mt
9
estrogen methyltestosterone
8
supplementation risk
8
esterified estrogen
8
exclusive cee+mt
8
conjugated esterified
8
association cee+mt
8
women
6
breast
6
cancer
6
risk
5
association
5
95%
5
cee+mt irrespective
4
models estimate
4
hazards models
4
proportional hazards
4

Similar Publications